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Abstract
In addition to providing life-giving nutrients and other substances to the breastfed infant, human milk can also
represent a vehicle of pathogen transfer. As such, when an infectious disease outbreak, epidemic, or pandemic
occurs—particularly when it is associated with a novel pathogen—the question will naturally arise as to
whether the pathogen can be transmitted through breastfeeding. Until high-quality data are generated to answer
this question, abandonment of breastfeeding due to uncertainty can result. The COVID-19 pandemic, which was
in full swing at the time this document was written, is an excellent example of this scenario. During these times
of uncertainty, it is critical for investigators conducting research to assess the possible transmission of path-
ogens through milk, whether by transfer through the mammary gland or contamination from respiratory
droplets, skin, breast pumps, and milk containers, and/or close contact between mother and infant. To promote
the most rigorous science, it is critical to outline optimal methods for milk collection, handling, storage, and
analysis in these situations, and investigators should openly share their methods in published materials.
Otherwise, the risks of inconsistent test results from preanalytical and analytical variation, false positives, and
false negatives are unacceptably high and the ability to provide public health guidance poor. In this study, we
provide ‘‘best practices’’ for collecting human milk samples for COVID-19 research with the intention that this
will also be a useful guide for future pandemics.
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Human milk is a complex emulsion consisting of a vastarray of constituents providing not only nutrition but
also protection from pathogens. Concentrations of these
constituents vary within an individual, across the lactation
period, and even within a feed. Although we do not under-
stand all the factors driving this variability, we know a sub-
stantial amount regarding how some factors influence
concentrations of some milk constituents. For instance, total
lipid content of milk is affected by time postpartum, time of
day, time since last feeding, portion of an individual feed
(fore- versus hindmilk), maternal body fat level, and in some
cases maternal diet.1–4 To complicate matters, lipids and cells
can adhere to some types of collection containers that can
impact research results,5 and some milk constituents (e.g.,
viral particles and RNA) can be entrapped in the lipid fraction
or other compartments such as exosomes.6–10
Researchers studying human milk composition should,
therefore, consider these factors when designing their pro-
tocols for collecting human milk to study its composition. For
example, collecting a foremilk sample in the morning using
an inappropriate collection container may easily lead to in-
accurate quantification of milk’s lipophilic compounds. An-
other example is host RNA, which, although in relatively
high concentrations in milk, is quickly degraded by intrinsic
RNases3,11; as such, milk must be immediately processed or
snap frozen for accurate quantification of host RNA. For
other constituents (e.g., iron and lactose), concentrations in
milk are less prone to variation12,13; in these situations,
sample collection and storage protocols can be less stringent.
Milk composition may even vary between breasts—
especially regarding immune factors; this fact has been par-
ticularly important in the study of HIV transmission through
breastfeeding.14 For other milk components, such as micro-
biota, there exists very little research characterizing modifi-
able factors (e.g., time of day and time within feed) related to
variation; in these situations, best practices and standardi-
zation (although not optimization) are typically employed to
ensure that samples are collected in a way that reduces risk of
contamination and allows data to be compared across studies.
In summary, because human milk composition is highly
variable within and among women and can be influenced by
many biological and methodological factors, it is funda-
mentally important that researchers consider and report core
aspects of milk collection, handling, and storage when
studying it. These aspects include expression mode (electric
pump or manual expression), time of day, time postpartum,
complete versus partial expression (and if the latter, whether
foremilk or hindmilk was collected), breast preparation (was
the breast cleaned and if so with what), collection container
material (and whether it was sterile), and storage conditions
(e.g., time until refrigeration or freezing, temperature, and
duration of storage). In addition, sometimes chemical pre-
servatives are utilized, and these should be carefully evalu-
ated as to whether they might impact the researcher’s ability
to detect the milk constituent of interest.
The primary purpose of this document is to, using evidence
gleaned from the literature and expert opinion, delineate a
‘‘best practices’’ framework related to human milk collec-
tion, handling, and storage for COVID-19 research related to
breastfeeding. Although we recognize that each microbe is
unique, it is our hope that this framework will also be ap-
plicable to other pathogenic RNA viruses, DNA viruses,
bacteria, and maybe even other organismal taxa. In addition
to including information related to the study of presence/
absence and viability of these types of pathogens, we provide
information on how one might best collect milk for the study
of immunoglobulins, cytokines, and other soluble factors,
and immune cells as these components are typically studied
in this context.
Investigators collecting milk for research during an out-
break, epidemic, or pandemic are urged to consider this
framework and best practices both in designing their methods
and in reporting their findings. Depending on the research
question, not all elements of the framework may be relevant;
nor may each element be feasible given the patient population
and environmental context. However, it is critical for the
interpretation of results and to guarantee comparability of
findings across studies that key elements of milk collection,
handling, and storage be described in published materials. It
is noteworthy that this framework and associated best prac-
tices will undoubtedly shift as new data emerge related to the
nature of the pathogen and how collection and storage con-
ditions do or do not impact the ability to detect and quantify
them. Indeed, ‘‘best practices’’ will need to be periodically
revised to reflect the evolving state of the science.
Basic Working Definitions Related to Human
Milk Research
To help investigators navigate the somewhat unique vo-
cabulary of human milk and lactation research, selected terms
have been briefly defined and are provided in Table 1. Many
of these definitions are adapted from those provided in Lac-
taPedia,15 which is an excellent resource in this respect.
Framework
In this study, we briefly review the literature describing
whether or not selected factors known to impact the con-
centration and/or stability of some milk components impact a
set of components particularly pertinent to research related to
potential transmission of pathogens from mother to infant
through human milk and/or breastfeeding. These components
and attributes include viral DNA and RNA, bacterial DNA,
microbial viability, immunoglobulins, cytokines and other
soluble components, and immune cells. This information is
important because it informs what should be considered,
controlled for, or at least reported when human milk is being
collected, handled, and stored for this type of research.
Table 2 provides a summary of these factors and provides
guidance as to whether they should be controlled for and/or
reported in studies related to transmission of a pathogen in
milk. It is noteworthy that the state of the science for many of
these factors is insufficient, and additional research is ur-
gently needed to fill these knowledge gaps.
Time postpartum
Whereas little is known regarding whether time postpar-
tum per se impacts viral RNA, DNA, and viral viability,
some evidence suggests that bacterial profiles and load in
milk change over time and particularly between colostrum
and mature milk.16–18 In addition, myriad studies have


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































documented an effect of time postpartum on concentrations
of immunoglobulins, cytokines soluble factors, and immune
cell populations.19–21 For instance, sIgA concentrations in
milk decline precipitously from birth to 2 weeks postpar-
tum22; macrophages, lymphocytes, and lactoferrin continue
to decrease through 3 months postpartum23; and lysozyme
increases.20 Immune cell concentrations also increase during
involution, which is generally associated with later times
after parturition,23 and during mastitis, which is most com-
mon in the first several weeks of lactation.24,25
As such, an attempt should be made to standardize and/or
control for time postpartum and breast health (subclini-
cal/clinical mastitis versus none) when comparing data across
cohorts (e.g., infected versus noninfected breastfeeding
women), and time postpartum when milk was collected
should always be reported in publications. In addition, be-
cause composition of milk can be affected by premature
delivery, whether the infant was born premature or full term
should be noted.
Time of day
There is very little published literature rigorously investi-
gating if there is diurnal variation in concentrations of bac-
terial and viral RNA and DNA, bacterial and viral viability,
immunoglobulins, and cytokines and other soluble factors in
milk. Limited data, however, suggest that antibody and cy-
tokine concentrations may vary over the course of a day.26,27
A variety of hormones (many of which are known to impact
immune function) also vary throughout the day and night.28
Cell content of human milk may also be influenced by the
circadian cycle of cortisol, but very little is known about
this.29 As such, if collecting repeated milk samples from a
woman over time, researchers might consider standardizing
the time of day the samples were collected. Alternatively,
researchers could employ the ‘‘gold standard’’ approach of
collecting complete breast expressions for a 24-hour period
and analyzing a representative (composite) sample. If this 24-
hour collection methodology is not used, researchers should
consider recording time of sample collection in the metadata.
Foremilk versus hindmilk
There is substantial evidence that the lipid content of milk
is lower in foremilk than in hindmilk,2,30–32 and that this is
likely related to the time since last feeding.33 Whereas some
studies have documented lower protein content in foremilk
than hindmilk,34–36 others found no difference33 or the op-
posite.37,38 Limited evidence also suggests that cell content is
higher in hindmilk than foremilk.33 To our knowledge, there
are no published data using molecular methods relating
foremilk versus hindmilk to variation in detectable microbial
communities (or their viability), although Rodrı́guez-Cruz
et al. found no difference in microbial profiles between whole
milk and skim milk.39 Nonetheless, if the microbe of interest
is lipophilic it is possible that it might be found in lower
abundance if only foremilk is collected. Because of the po-
tential for differential milk composition within a feed (ex-
pression) and the dearth of data related to this factor and
microbes, antibodies and other soluble factors, and cells in
milk, researchers should report whether and how a complete
expression was collected, and if not whether foremilk or
hindmilk was primarily obtained, and time since last feed.
Expression mode
Breast pump parts (including tubing) can be contaminated.
Consequently, if breast pumps are used, they must be thoroughly
disinfected and rinsed to remove all viral/bacterial DNA and
RNA and disinfectant. Since foremilk is generally lower in fat
than hindmilk, expression mode (hand versus other and complete
expression versus partial) might also impact ability to detect a
pathogen if it compartmentalizes to the lipid fraction of milk.
Nonetheless, Rodrı́guez-Cruz et al. found no difference in mi-
crobial profiles between collected through manual expression
and that collected with a pump.39 If hand expression is employed,
subjects should thoroughly wash their hands and/or wear clean
gloves. Researchers should report if milk was collected using a
manual pump, electric pump (and type), or hand expression.
Importantly, both researchers and study participants
should follow recommended infection prevention and control
measures during the collection and handling of the milk.
Depending on the cultural norm, women may be comfortable
using breast pumps or using hand expression to express milk;
but if not, instruction should be provided by a qualified lac-
tation consultant or personnel with suitable expertise.
Interbreast variation and inflammation
For some milk constituents there can be interbreast varia-
tion, and mammary inflammation is known to drive some of
these differences. For instance, levels of HIV RNA can differ
in milk produced by each breast,40 largely due to differences in
mammary inflammatory status.41 Almost nothing is known
about intergland difference in other types of pathogens. Pan-
naraj et al. compared milk microbiomes between healthy hu-
man breasts and found no difference42; although studies of
dairy cows clearly show that mastitic and healthy glands
produce milk with different microbial profiles.43 It is likely
that whether there are differences in milk microbiome between
mammary glands can depend on mammary health. Because of
potential differences in microbial proteins in milk produced by
each breast (likely due to inflammation), researchers should
ideally collect milk from both breasts; if that is not possible,
they should aim to evaluate mammary inflammation either
visually (e.g., redness) or chemically in the milk sample (e.g.,
Na/K ratios, cytokines, and somatic cell count).
Breast preparation
Depending on whether the pathogen is primarily blood-
borne, respiratory-borne, or environmental, it is possible that
some pathogens may be present on the breast skin. None-
theless, whether the breast should or should not be cleaned is
related to the question at hand. If the question relates to
whether the pathogen is incorporated into milk in the mam-
mary gland, then the breast should be cleaned before milk
collection. If the question relates to whether the infant might
be exposed to the pathogen through breastfeeding or the
consumption of pumped milk, then the breast should not be
cleaned. If the question relates to antibody or cytokine con-
tent of milk, breast cleaning is irrelevant. Researchers should
design their collection methods to suit their research question
and describe whether/how the breast was cleaned.
Collection containers
Some milk components (e.g., lipids and cells) can adhere
to certain materials common to collection containers. Others
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(e.g., sIgA) have been demonstrated to be stable in both glass
and plastic containers.44 Given the inadequate state of the
science regarding the importance (or lack thereof) of col-
lection container materials to studying microbes in milk,
however, there is no recommendation as to what sort of
collection container should be used. This information
should be reported, however, in any publication.
Temperature and storage
Refrigeration, freezing, thawing, and application of heat
can all affect the stability of many milk components.45–47 In
addition, some subpopulations of cells can only be isolated
from fresh milk, as they are destroyed or altered by freezing
and/or thawing. Conversely, HIV RNA levels have been
shown to be remarkably stable in whole milk after three
freeze–thaw cycles and for up to 30 hours at room tempera-
ture,48 and some data suggest that milk can be stored at 4C
for up to 48 hours or at -20C or -80C for at least 6 months
without losing its immunological properties.49 For bacterial
DNA, Doyle et al. found very little impact of refrigeration
temperature (2C, 4C, or 6C) and storage duration (up to 96
hours) on bacterial profiles (through 16S rRNA analysis) in
bovine milk.50 There are similar findings for human milk.51,52
Although findings are somewhat mixed,53–55 there is
substantial evidence that some soluble factors and charac-
teristics (e.g., antioxidant capacity) in milk can be influenced
by refrigeration and freezing, whereas others (e.g., human
milk oligosaccharides) are extraordinarily stable.56–58 It has
been shown that prolonged storage at 4C reduces the in-
fectious titer of hepatitis C and Zika virus that has been
spiked into milk.59–61
To date, little is known about the stability of SARS-CoV-2
during cold storage, although study from our group suggests
that SARS-CoV-2 RNA in milk may be stable for 2 days at
4C and 7 days at -20C and can withstand several freeze–
thaw cycles.62,63 It is unclear what the impact of freezing and
thawing on infectivity would be. However, Walker et al.64
provide evidence that Holder pasteurization (but not cold
storage) inactivates SARS-CoV-2; Unger et al.65 and
Chambers et al.66 have also shown that Holder pasteurization
inactivates SARS-CoV-2 and the former that holding milk at
room temperature for 30 minutes also reduces infectious viral
titers.
Because they can be destroyed and/or inactivated by
temperature changes, care should also be taken to avoid re-
peat free thaw cycles of milk collected to measure the anti-
bodies to SARS-CoV-2.67,68 In considering the cytopathic
effects of viruses (e.g., SARS-CoV-2 and Ebola), researchers
need to be aware that the multitude of immune components in
human milk with significant antiviral activity may immedi-
ately impact cytopathic activity when milk is held at room
temperature or 4C.64,69
In summary, researchers are encouraged to consider
whether the milk component of interest is stable under the
available storage conditions and, similar to all important
factors, report the temperature at which milk was stored be-
fore analysis. If in doubt, it is always safest to analyze fresh
milk or freeze it at the lowest temperature possible as soon as
possible and keep it frozen until it is analyzed. Creating ali-
quots of the sample is often advised to avoid freeze–thaw
cycles of samples.
Milk fraction
When detecting SARS-CoV-2 RNA through quantitative
PCR in spiked milk samples, defatted milk yielded better
recovery rates than did whole milk.63 Conversely, up to one-
third of HIV RNA in milk produced by infected women may
be sequestered in the lipid fraction.7 Rodrı́guez-Cruz et al.
found no difference in bacterial profiles between whole milk
and skim milk.39
Best Practices for Milk Collection and Storage
Hereunder, we provide ‘‘best practices’’ for research pur-
poses in various settings, recognizing that what is possible,
ethical, and desirable depends greatly on the research ques-
tion, context, and capabilities of each research group as well
as maternal and infant factors.
Step 1. Breast cleaning
If the research question is related to exposure of the infant to
the pathogen through the complex process of breastfeeding
(‘‘breastfeeding transfer’’) or consuming pumped milk, it is
unnecessary to clean the breast. However, if the research ques-
tion is related to whether the pathogen is transmitted through the
mammary gland into milk (‘‘milk transfer’’), the breast should
be thoroughly cleaned before milk collection—particularly if the
pathogen may be transmitted into milk through respiratory
droplets. After donning face covering and a glove on the hand
that will clean the breast, research personnel or the mother
(depending on cultural acceptability) should clean the ‘‘study
breast’’ thoroughly with soap and sterile water or aseptic wipes.
The purpose of this step is to physically remove skin pathogens.
Step 2. Milk collection
Using one of the methods detailed hereunder, collect milk
from the chosen breast. Depending on which milk constituent
is of interest, this milk can be foremilk, hindmilk, or a
combination, thereof. If, for some reason, not enough milk
can be expressed from the chosen breast, it is generally ac-
ceptable to combine milk from both breasts and document
how the composite sample was created. If this is needed, the
‘‘second’’ breast should be cleaned (as appropriate to the
research question) as described in Step 1 before collecting
milk. The following options are equally acceptable.
Option A: Hand expression. With a newly gloved hand,
the mother should express the needed volume of milk into the
sterile collection container. The goal is to obtain a ‘‘clean
catch’’ sample that drips or squirts directly from the nipple
into the sterile container.
Option B: Electric or manual pump. Using a sterile or
thoroughly cleaned and disinfected pump (including attach-
ments, and tubing) have the mother express the needed
amount of milk into the sterile collection container.
Step 3. Milk partitioning and storage
Option A (preferred): To be used when refrigeration/cold
box is available at site and freezer is available in nearby
laboratory
 Place milk immediately in refrigerator, ice, ice box, or
cold box. If the research question is related to isolating
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Table 3. Metadata to Consider, Collect, and/or Report When Studying Human Milk in Light
of an Infectious Disease
Related to milk collection and handling methods
O Type of milk collected Foremilk, hindmilk, complete breast expression, and composite
O Mode of collection Hand expression, electric pump, and manual pump
O Breast(s) collected Right, left, and both
O Collection/storage containers Glass, polypropylene, sterile, etc.
O Preservative added? If yes, what kind?
O Storage conditions Temperature, duration, and freeze–thaw cycles
Additional metadata that should be collected and reported if possible
O Time postpartum, and term versus
preterm
Colostrum, transitional milk, mature milk, and gestational age
(preterm versus term)
O Time of day Morning, afternoon, and evening
O Time since last feed Hours since last feeding or pumping session
O Breastfeeding practices Exclusively breastfed at the breast, fed pumped milk, and mixed
feeding
O Inflammatory state of breast Na/K ratio, cytokine profile, somatic cell count, breast redness, and
breast pain
7
infectious virus, the sample might need to be snap
frozen or analyzed immediately.
 If possible, aliquot milk; transfer milk using sterile
pipet into sterile storage containers.
 As soon as possible, freeze milk at -20C or (prefera-
ble) -80C.
Option B: To be used when refrigeration/freezing is not
available
 Within 30 minutes of milk collection, treat milk with
appropriate and validated chemical preservative (e.g.,
Norgen Biotek Corporation’s Milk DNA Preservation
and Isolation Kit). Preservatives should have been
tested and validated for use with human milk to ensure
that they do not destroy or destabilize milk components
of interest or interfere with assays. These preservatives
likely impact viral/bacterial viability.
 Store in a cool place, at ambient temperature, or as
described in manufacturer’s instructions.
When milk supply is limited
Special care should be taken in situations when milk
supply is limited and/or when the infant’s health is at risk, for
example, in the very early postpartum period (colostrum
samples) and when the infant is very preterm and/or at risk for
developing necrotizing enterocolitis. In these situations, re-
searchers are encouraged to modify the methods described
earlier so that the volume of milk available to the infant is not
jeopardized. In general, only very small amounts (typically
<1 mL) of colostrum should be collected. Sufficient milk may
sometimes be obtained from a sterile swab to enable testing
of SARS-CoV-2 gene targets through reverse transcription-
qPCR testing.70 In many clinical settings, enteral feeds for
very preterm or hospitalized infants are prepared in a central
milk preparation room in a batch to last 12–24 hours. Often a
small volume of milk that would otherwise be discarded can
be collected for research purposes and uniquely reflects what
an infant would receive the following day.
Ethical considerations
All procedures should be approved by local, regional,
and/or national ethics boards (as appropriate) to protect
participants’ rights and ensure that subjects’ identities are not
linked to resultant data. For instance, samples and data should
always be deidentified from subjects’ names. Each mother
should provide informed consent for milk collection, under-
stand the purpose of the study, and be reassured that samples
will be neither used for other purposes nor sold. Not all the
mothers will have the same educational level, so it may be
necessary to take extra care when communicating the pur-
pose of the study. Particularly in studies with indigenous
populations, researchers must understand how participants
may view the collection of human milk and its use for bio-
chemical analysis within the prevailing worldview.
Regarding safety
Researchers working directly with infected breastfeeding
women should always follow all infection control and safety
recommendations put forth by local, national, and interna-
tional organizations—including the use of masks, gowns, and
gloves. In addition, samples should be processed in an ap-
propriate biosafety cabinet, if available.
Checklist for collecting human milk in light
of an infectious disease
A checklist of important factors that should be considered,
documented, and reported when collecting human milk to
study potential transmission of a pathogen through breast-
feeding is provided in Table 3.
Regarding the State of the Science and Urgency
As briefly described in this document, there are myriad
gaps in knowledge related to studying the presence/absence
of pathogens in human milk; their origin, when they are
present; and their ability to be adequately characterized in
terms of load and viability. This dearth of knowledge makes
quickly assessing risk versus benefit of breastfeeding during
a pandemic difficult. In these situations, we encourage re-
searchers to work collaboratively and quickly to develop
specialized protocols as needed and openly share information
with other researchers so that accurate answers are gleaned in
a timely manner. To facilitate this, granting agencies are
encouraged to make emergency funding available to engaged
and qualified research groups, and to facilitate contact be-
tween groups in the interest of collaboration.
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